Evidence map›Paper›PMID 25767713›Full record

ArticleClinical case reports2015

Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal.

Samuel Michael Lipski, Georges Casimir, Martine Vanlommel, Mathieu Jeanmaire, Pierre Dolhen

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Efficacy of Treatment of Non-hereditary Angioedema.Clinical reviews in allergy & immunology · 2018
    Pooled it
  2. Review
  3. Evaluation and Management of Angioedema in the Emergency Department.The western journal of emergency medicine · 2019
    Review
  4. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.Journal of clinical hypertension (Greenwich, Conn.) · 2017
    Review
  5. Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck.GMS current topics in otorhinolaryngology, head and neck surgery · 2016
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Samuel Michael LipskiEar-Nose-Throat Department, Tivoli University Hospital, Free University of Brussels Brussels, Belgium.
Georges CasimirPulmonology and Allergology Unit, University Children's Hospital Queen Fabiola, Free University of Brussels Brussels, Belgium.
Martine VanlommelEar-Nose-Throat Department, Tivoli University Hospital, Free University of Brussels Brussels, Belgium.
Mathieu JeanmaireEmergency Department, Tivoli University Hospital, Free University of Brussels Brussels, Belgium.
Pierre DolhenEar-Nose-Throat Department, Tivoli University Hospital, Free University of Brussels Brussels, Belgium.
French Community of Belgium · BECentre Hospitalier Universitaire de Tivoli · BEQueen Fabiola Children's University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C1 esterase inhibitor (Berinert®) is generally used to treat severe attack of hereditary angioedema. We describe here the case of a patient who presented with a severe angioedema induced by angiotensin-converting enzyme inhibitors (ACEIs) endangering her life. It could be successfully treated with that medicine.

Indexed as

Angioedemaangiotensin-converting enzyme inhibitorsC1 esterase inhibitortreatmentupper airways

Identifiers

PMID25767713
PMCPMC4352369
OpenAlexW2064172350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.